How relates lifetime prevalence of skin cancer to sexual orientation

Last Updated on

February 16, 2020 – An often asked question is whether there is an association between sexual orientation and lifetime prevalence of skin cancer. According to a cross-sectional study of 845’ 264 adults in the US, just published in JAMA Dermatology as recent as February 12, 2020, the answer to this question would be a sounding yes. Both gay and bisexual men had higher adjusted odds (see also odds-ratio in this context) of lifetime prevalence of skin cancer compared with heterosexual men. In contrast, bisexual women, but not lesbian women, had lower odds of lifetime prevalence of skin cancer compared with heterosexual women.
Particularly worrying seem the higher odds in gay and bisexual men for skin cancers when compared to heterosexuell men. The question arises if these groups of male individuals expose themselves knowingly or unknowingly to a higher degree of risk factors eventually leading to skin cancer than their heterosexuell counterparts.
In the present study, data from the 2014-2018 Behavioral Risk Factor Surveillance System (BRFSS) surveys of a noninstitutionalized population in the United States that included 845 264 adult participants who self-identified as being heterosexual, gay, lesbian, or bisexual were analyzed. Thus, the study included 845’ 264 participants, including 351’ 468 heterosexual men (mean age, 47.7; 95% CI, 47.5-47.8), 7’516 gay men (mean age, 42.7; 95% CI, 41.9-43.5), 5’088 bisexual men (mean age, 39.3; 95% CI, 38.2-40.4), 466’ 355 heterosexual women (mean age, 49.7; 95% CI, 49.6-49.9), 5’392 lesbian women (mean age, 41.9; 95% CI, 40.7-43.2), and 9’445 bisexual women (mean age, 32.7; 95% CI, 32.2-33.2). The adjusted odds ratios (AORs) of skin cancer prevalence were significantly higher among both gay (AOR, 1.26; 95% CI, 1.05-1.51; P = .01) and bisexual men (AOR, 1.48; 95% CI, 1.02-2.16; P = .04) compared with heterosexual men. The AORs of skin cancer were statistically significantly lower among bisexual women (AOR, 0.78; 95% CI, 0.61-0.99; P = .04) but not among gay or lesbian women (AOR, 0.97; 95% CI, 0.73-1.27; P = .81) compared with the AORs of skin cancer among heterosexual women. Thus, gay and bisexual men in this study had an increased self-reported lifetime prevalence of skin cancer compared with the prevalence among heterosexual men.
When it comes to identification of possible risk factors, then it is noteworthy that sexual minority men have self reported higher rates of both indoor tanning than heterosexual men, and sexual minority women have self reported lower or equal rates of indoor tanning compared with heterosexual women. Bisexual men, in particular, have reported higher rates of indoor tanning bed use than heterosexual men; however, no study has investigated skin cancer prevalence among gay, lesbian, and bisexual individuals as separate groups.
Overall, sexual and gender minority (SGM) persons include, but are not limited to, individuals who identify as lesbian, gay, bisexual, or transgender, as well as individuals whose sexual orientation, gender identity or expression, or reproductive development are characterized by nonbinary constructs of sexual orientation, gender, and/or sex. Population-based data on skin cancer epidemiology in SGM persons remain inadequate. Without robust epidemiologic data, it is challenging for dermatologists to recognize and articulate their specific roles within broader national conversations on improving SGM health. Emerging skin cancer data, particularly among gay and bisexual men, as noted in the present study, indicate unmet needs for skin cancer prevention in specific SGM subpopulations. Moreover, continued implementation of the Behavioral Risk Factor Surveillance System’s sexual orientation and gender identity module is imperative to improve understanding of the health and well-being of sexual minority populations.
It would also be interesting to know, which types of skin cancers are more prevalent in these populations. One could easily imagine that certain skin cancer types arise specifically in dependence of the underlying risk factors sexual minority populations expose themselves, tanning and increased tanning bed time just being one example in case.
See here a short sequence on types of skin cancers:

Print Friendly, PDF & Email

Tags: , , , , ,
About the Author
Joseph Gut - thasso Ph.D.; Professor in Pharmacology and Toxicology. Senior expert in theragenomic and personalized medicine and individualized drug safety. Senior expert in pharmaco- and toxicogenetics. Senior expert in human safety of drugs, chemicals, environmental pollutants, and dietary ingredients.

Your opinion

Comment

No comments yet

thasso: conditions

thasso: newest tweets

thasso: recent comments

thasso post: magazine

View my Flipboard Magazine.

thasso: categories

thasso: archives

thasso: simple chat

You must be a registered user to participate in this chat.

  • Study of rare genetic disorder that effects the eyes April 3, 2020
    Nagano prefecture is home to a group of people affected with a rare genetic neurodegenerative disorder called familial amyloid polyneuropathies (FAP). This disease impacts the gene encoding protein transthyretin (TTR) which is produced in the liver and also eyes. Liver transplants are often a treatment for this disease, but severe eyesight problems such as cloudiness […]
  • Natural sunscreen gene influences how we make vitamin D April 2, 2020
    Genetic variations in the skin can create a natural sunscreen, according to University of Queensland researchers investigating the genes linked with vitamin D.
  • Single mutation leads to big effects in autism-related gene April 2, 2020
    A new study in Neuron offers clues to why autism spectrum disorder (ASD) is more common in boys than in girls. National Institutes of Health scientists found that a single amino acid change in the NLGN4 gene, which has been linked to autism symptoms, may drive this difference in some cases. The study was conducted […]
  • Lifestyle changes could delay memory problems in old age, depending on our genes April 2, 2020
    Researchers from King's College London have shown that how we respond to changes in nutrients at a molecular level plays an important role in the aging process, and this is directed by some key genetic mechanisms.
  • Geneticists are bringing personal medicine closer for multiracial individuals April 2, 2020
    A new study in Nature Communications proposes a method to extend polygenic scores, the estimate of genetic risk factors and a cornerstone of the personalized medicine revolution, to individuals with multiple ancestral origins. The study was led by Dr. Davide Marnetto from the Institute of Genomics of the University of Tartu, Estonia and coordinated by […]
  • Study of rare genetic disorder that effects the eyes April 3, 2020
    Small gauge vitrectomy for vitreous amyloidosis and subsequent management of secondary glaucoma in patients with hereditary transthyretin amyloidosis.
  • Tissue dynamics provide clues to human disease April 3, 2020
    Scientists in EMBL Barcelona's Ebisuya group, with collaborators from RIKEN, Kyoto University, and Meijo Hospital in Nagoya, Japan, have studied oscillating patterns of gene expression, coordinated across time and space within a tissue grown in vitro, to explore the molecular causes of a rare human hereditary disease known as spondylocostal dysostosis. Their results are published […]
  • Coronavirus: Virological findings from patients treated in a Munich hospital April 3, 2020
    In early February, research teams from Charité - Universitätsmedizin Berlin, München Klinik Schwabing and the Bundeswehr Institute of Microbiology published initial findings describing the efficient transmission of SARS-CoV-2. The researchers' detailed report on the clinical course and treatment of Germany's first group of COVID-19 patients has now been published in Nature*. Criteria may now be […]
  • Case study: Treating COVID-19 in a patient with multiple myeloma April 3, 2020
    A case study of a patient in Wuhan, China, suggests that the immunosuppressant tocilizumab may be an effective COVID-19 treatment for very ill patients who also have multiple myeloma and other blood cancers. The report, published in Blood Advances, also suggests that blood cancer patients may have atypical COVID-19 symptoms.
  • Indigenous American ancestry may be associated with HER2-positive breast cancer April 3, 2020
    An increased proportion of Indigenous American (IA) ancestry was associated with a greater incidence of HER2-positive breast cancer, according to a study published in Cancer Research, a journal of the American Association for Cancer Research.
Top